Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention

OBJECTIVE: The aim of this study was to investigate the atherothrombotic and bleeding risk of discontinuing both components of dual antiplatelet therapy (DAPT) before surgery in patients with an intracoronary stent after 1 year. METHODS: We retrospectively enrolled 212 patients who received an evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jeen Hwa, Jo, Sang Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379090/
https://www.ncbi.nlm.nih.gov/pubmed/32821739
http://dx.doi.org/10.12997/jla.2020.9.2.304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379090/
https://www.ncbi.nlm.nih.gov/pubmed/32821739
http://dx.doi.org/10.12997/jla.2020.9.2.304

Ejemplares similares